Paul Barrow

739 total citations
52 papers, 407 citations indexed

About

Paul Barrow is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Paul Barrow has authored 52 papers receiving a total of 407 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pediatrics, Perinatology and Child Health, 13 papers in Molecular Biology and 9 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Paul Barrow's work include Pharmaceutical studies and practices (16 papers), Effects and risks of endocrine disrupting chemicals (9 papers) and Pregnancy and Medication Impact (8 papers). Paul Barrow is often cited by papers focused on Pharmaceutical studies and practices (16 papers), Effects and risks of endocrine disrupting chemicals (9 papers) and Pregnancy and Medication Impact (8 papers). Paul Barrow collaborates with scholars based in Switzerland, United Kingdom and France. Paul Barrow's co-authors include Georg Schmitt, Neil Parrott, Jeanne Stadler, Eric Prinssen, Nicole Clemann, Robert B. Brown, Isabelle Leconte, Colin J. Barrow, Françoise Horand and Alain Rougier and has published in prestigious journals such as PLoS Computational Biology, Toxicological Sciences and Toxicology.

In The Last Decade

Paul Barrow

48 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Barrow Switzerland 13 112 107 69 63 52 52 407
Margaret C. Neville United States 10 87 0.8× 266 2.5× 48 0.7× 44 0.7× 15 0.3× 14 699
Xinghua Huang China 12 71 0.6× 198 1.9× 36 0.5× 25 0.4× 21 0.4× 43 506
Akinobu Okada Japan 11 88 0.8× 156 1.5× 81 1.2× 95 1.5× 48 0.9× 23 426
Gbolagade O. Babalola United States 8 72 0.6× 259 2.4× 118 1.7× 99 1.6× 13 0.3× 12 504
Amy Moore United States 11 39 0.3× 136 1.3× 79 1.1× 31 0.5× 8 0.2× 32 394
Maria Grazia Mascolo Italy 14 20 0.2× 235 2.2× 54 0.8× 32 0.5× 65 1.3× 29 509
Martin B. Lee Singapore 12 64 0.6× 287 2.7× 40 0.6× 53 0.8× 9 0.2× 17 555
Michael T. Rae United Kingdom 21 374 3.3× 199 1.9× 142 2.1× 221 3.5× 31 0.6× 42 1.1k
Brigitte Robert France 15 97 0.9× 145 1.4× 69 1.0× 56 0.9× 8 0.2× 25 499
J. Kleinstein Germany 12 103 0.9× 103 1.0× 60 0.9× 190 3.0× 88 1.7× 37 610

Countries citing papers authored by Paul Barrow

Since Specialization
Citations

This map shows the geographic impact of Paul Barrow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Barrow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Barrow more than expected).

Fields of papers citing papers by Paul Barrow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Barrow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Barrow. The network helps show where Paul Barrow may publish in the future.

Co-authorship network of co-authors of Paul Barrow

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Barrow. A scholar is included among the top collaborators of Paul Barrow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Barrow. Paul Barrow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barrow, Paul. (2024). Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2022 and 2023. Reproductive Toxicology. 130. 108727–108727. 2 indexed citations
2.
Zhang, Jitao David, Nicole Schäfer, Nicole Clemann, et al.. (2022). Optimization of the TeraTox Assay for Preclinical Teratogenicity Assessment. Toxicological Sciences. 188(1). 17–33. 10 indexed citations
3.
Schmitt, Georg & Paul Barrow. (2022). Considerations for and against dosing rodent pups before 7 days of age in juvenile toxicology studies. Reproductive Toxicology. 112. 77–87. 4 indexed citations
4.
Barrow, Paul. (2022). Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2020 and 2021.. Reproductive Toxicology. 112. 100–108. 3 indexed citations
5.
Ayuso, Miriam, Chris Van Ginneken, Isabelle Leconte, et al.. (2021). Safety Testing of an Antisense Oligonucleotide Intended for Pediatric Indications in the Juvenile Göttingen Minipig, including an Evaluation of the Ontogeny of Key Nucleases. Pharmaceutics. 13(9). 1442–1442. 4 indexed citations
6.
7.
Zhang, Jitao David, Paul Barrow, Martin Ebeling, et al.. (2020). Focus on germ-layer markers: A human stem cell-based model for in vitro teratogenicity testing. Reproductive Toxicology. 98. 286–298. 12 indexed citations
8.
Barrow, Paul & Nicole Clemann. (2020). Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2018 and 2019. Reproductive Toxicology. 99. 144–151. 11 indexed citations
9.
Barrow, Paul & Georg Schmitt. (2017). Juvenile Nonclinical Safety Studies in Support of Pediatric Drug Development. Methods in molecular biology. 1641. 25–67. 4 indexed citations
10.
Schmitt, Georg, Neil Parrott, Eric Prinssen, & Paul Barrow. (2017). The great barrier belief: The blood–brain barrier and considerations for juvenile toxicity studies. Reproductive Toxicology. 72. 129–135. 32 indexed citations
11.
Barrow, Paul, et al.. (2017). Reproductive and developmental toxicology studies with gantenerumab in PS2APP transgenic mice. Reproductive Toxicology. 73. 362–371. 8 indexed citations
12.
Barrow, Paul. (2016). Revision of the ICH guideline on detection of toxicity to reproduction for medicinal products: SWOT analysis. Reproductive Toxicology. 64. 57–63. 16 indexed citations
13.
Barrow, Paul, et al.. (2016). Review of embryo-fetal developmental toxicity studies performed for recent FDA-approved pharmaceuticals. Reproductive Toxicology. 64. 98–104. 11 indexed citations
14.
Barrow, Paul, et al.. (2012). The Teratology Testing of Cosmetics. Methods in molecular biology. 947. 91–94. 2 indexed citations
15.
Barrow, Paul, et al.. (2009). Juvenile toxicity of cyclosporin in the rat. Reproductive Toxicology. 28(2). 230–238. 5 indexed citations
16.
Barrow, Paul. (2009). Reproductive toxicity testing for pharmaceuticals under ICH. Reproductive Toxicology. 28(2). 172–179. 23 indexed citations
17.
Barrow, Paul. (2004). Raising finance : a practical guide to starting, expanding and selling your business. Kogan Page eBooks.
18.
Barrow, Paul. (2003). Reproductive toxicology studies and immunotherapeutics. Toxicology. 185(3). 205–212. 8 indexed citations
19.
Ishikawa, Atsuko, Michio Fujiwara, Takeji Ohata, et al.. (1997). Reproductive toxicity, mutagenicity and antigenicity of pamiteplase (genetical recombination).. The Journal of Toxicological Sciences. 22(3). 207–217. 1 indexed citations
20.
Barrow, Paul, Philippe Olivier, & Daniel Marzin. (1995). The reproductive and developmental toxicity profile of beta-cyclodextrin in rodents. Reproductive Toxicology. 9(4). 389–398. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Margaret C. Neville Breakdown of academic impact, for papers by Xinghua Huang Breakdown of academic impact, for papers by Akinobu Okada Breakdown of academic impact, for papers by Gbolagade O. Babalola Breakdown of academic impact, for papers by Amy Moore Breakdown of academic impact, for papers by Maria Grazia Mascolo Breakdown of academic impact, for papers by Martin B. Lee Breakdown of academic impact, for papers by Michael T. Rae Breakdown of academic impact, for papers by Brigitte Robert Breakdown of academic impact, for papers by J. Kleinstein
Rankless by CCL
2026